Literature DB >> 27412422

Prevalence and risk factors for functional bowel disorders in South China: a population based study using the Rome III criteria.

Y Long1, Z Huang1, Y Deng1, H Chu1, X Zheng1, J Yang2, Y Zhu1, M Fried3, M Fox3,4, N Dai1.   

Abstract

BACKGROUND: Functional bowel disorders (FBDs) such as irritable bowel syndrome (IBS) impact on quality of life and health care resources. It is uncertain whether patients with functional digestive symptoms have similar characteristics in different populations. This population-based study assessed the prevalence and identified risk factors for these disorders in South-East China.
METHODS: Five communities were selected at random and invitations distributed to a representative sample (block randomization). Questionnaires were completely supervised by investigators. Demographic and medical data with FBD symptoms (Rome III criteria), psychological condition, life event stress, and quality of life were collected. KEY
RESULTS: Functional bowel disorder prevalence was 41.6% in 1999/2115 (94.5%) completed questionnaires: 9.9% functional constipation (FC), 6.8% bloating (FB), 6.5% diarrhea (FD), 5.9% IBS (IBS-D 47.1%, IBS-M 23.9%, IBS-C 12.8%, IBS-U 16.2%), and 12.6% unspecified. Similar numbers of men and women had FBDs or IBS (overall; 51.3% male vs 48.7% female, P=.796); however, there was female predominance in FC (62.1%, P<.001) and FB (58.5%, P=.038). FBDs were associated with greater anxiety, depression, life event stress, and a lower quality of life compared with those without symptoms (all, P<.0001). Logistic regression identified medical co-morbidity, anxiety/depression, and life event stress as independent risk factors for these disorders. CONCLUSIONS & INFERENCES: Functional bowel disorders are as common in South China as in western populations. A similar number of men and women report FBDs and IBS. Only FC and FB are more prevalent in females. Independent risk factors associated with FBDs included physical and psychosocial stressors.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  functional bowel disorders; irritable bowel syndrome; prevalence; risk factors

Mesh:

Year:  2016        PMID: 27412422     DOI: 10.1111/nmo.12897

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  13 in total

1.  Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan.

Authors:  Masayoshi Ono; Mototsugu Kato; Shuichi Miyamoto; Momoko Tsuda; Takeshi Mizushima; Shouko Ono; Manabu Nakagawa; Katsuhiro Mabe; Soichi Nakagawa; Shuichi Muto; Yuichi Shimizu; Mineo Kudo; Shinichi Katsuki; Takashi Meguro; Naoya Sakamoto
Journal:  J Gastroenterol       Date:  2018-01-05       Impact factor: 7.527

2.  Comparison of therapeutic effects of different acupuncture and moxibustion therapies on irritable bowel syndrome: A protocol for systematic review and network meta-analysis.

Authors:  Jialei Guo; Li Yang; Jing He; Zhengming Yang
Journal:  Medicine (Baltimore)       Date:  2021-09-03       Impact factor: 1.817

3.  The impact of overlapping functional dyspepsia, belching disorders and functional heartburn on anxiety, depression and quality of life of Chinese patients with irritable bowel syndrome.

Authors:  Xin Yao; Yunsheng Yang; Shutian Zhang; Yu Shi; Qian Zhang; Yongjun Wang
Journal:  BMC Gastroenterol       Date:  2020-07-06       Impact factor: 3.067

4.  Irritable bowel syndrome and functional constipation management with integrative medicine: A systematic review.

Authors:  Liang Dai; Linda Ld Zhong; Guang Ji
Journal:  World J Clin Cases       Date:  2019-11-06       Impact factor: 1.337

5.  Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.

Authors:  Wei Wei; Hui-Fen Wang; Yu Zhang; Yan-Li Zhang; Bing-Yu Niu; Shu-Kun Yao
Journal:  World J Gastroenterol       Date:  2020-12-07       Impact factor: 5.742

6.  Subjective Taste and Smell Changes in Conjunction with Anxiety and Depression Are Associated with Symptoms in Patients with Functional Constipation and Irritable Bowel Syndrome.

Authors:  Jie Liu; Chaolan Lv; Dandan Wu; Ying Wang; Chenyu Sun; Ce Cheng; Yue Yu
Journal:  Gastroenterol Res Pract       Date:  2021-09-18       Impact factor: 2.260

7.  Comparative Transcriptome Analysis Reveals Relationship among mRNAs, lncRNAs, and circRNAs of Slow Transit Constipation.

Authors:  Shuai Yan; Yinzi Yue; Mingming Sun; Yinghui Chen; Xiaopeng Wang; Haihua Qian
Journal:  Biomed Res Int       Date:  2021-08-23       Impact factor: 3.411

8.  Intraoperative serosal extracellular mapping of the human distal colon: a feasibility study.

Authors:  Anthony Y Lin; Chris Varghese; Peng Du; Cameron I Wells; Niranchan Paskaranandavadivel; Armen A Gharibans; Jonathan C Erickson; Ian P Bissett; Greg O'Grady
Journal:  Biomed Eng Online       Date:  2021-10-16       Impact factor: 2.819

9.  Effects of Ellagic Acid on Oxidative Stress Index, Inflammatory Markers and Quality of Life in Patients With Irritable Bowel Syndrome: Randomized Double-blind Clinical Trial.

Authors:  Zahra Mirzaie; Ali Bastani; Ali Akbar Haji-Aghamohammadi; Mohammadreza Rashidi Nooshabadi; Bahman Ahadinezhad; Hossein Khadem Haghighian
Journal:  Clin Nutr Res       Date:  2022-04-27

10.  Quality of Evidence Supporting the Role of Acupuncture for the Treatment of Irritable Bowel Syndrome.

Authors:  Jinke Huang; Mengxiong Lu; Yijun Zheng; Jinxin Ma; Xiangxue Ma; Yitian Wang; Kunli Zhang; Fengyun Wang; Xudong Tang
Journal:  Pain Res Manag       Date:  2021-12-15       Impact factor: 3.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.